Reverse shoulder arthroplasty for rheumatoid arthritis since the introduction of disease-modifying drugs.
Devin R MangoldEric R WagnerRobert H CofieldJoaquin Sanchez-SoteloJohn W SperlingPublished in: International orthopaedics (2019)
The two and five year implant revision-free survival was 99%. The two and five year re-operation-free survival was 97%. Eighteen (24%) glenoid components required augmentation with corticocancellous autograft from the humeral head. There were two cases of glenoid loosening with gross changes in position. Patients experienced significant pain relief with a 92% satisfaction rate. Shoulder elevation and external rotation improved from 65 and 21 degrees pre-operatively to 138 and 45 degrees post-operatively, respectively (p < .01). Average ASES and SST scores were 72 and 7.0, respectively. The use of prednisone, DMARDs, or biologic medications had no significant impact on outcomes.
Keyphrases
- free survival
- rheumatoid arthritis
- end stage renal disease
- ejection fraction
- newly diagnosed
- chronic kidney disease
- total knee arthroplasty
- chronic pain
- soft tissue
- peritoneal dialysis
- disease activity
- pain management
- prognostic factors
- type diabetes
- neuropathic pain
- metabolic syndrome
- optic nerve
- spinal cord injury
- rheumatoid arthritis patients
- spinal cord
- total hip arthroplasty
- rotator cuff
- children with cerebral palsy